Bruton's Tyrosine Kinase-Mediated Signaling in Myeloid Cells Is Required for Protective Innate Immunity During Pneumococcal Pneumonia

被引:10
|
作者
de Porto, Alexander P. [1 ,2 ]
Liu, Zhe [1 ,2 ]
de Beer, Regina [1 ,2 ]
Florquin, Sandrine [3 ]
Roelofs, Joris J. T. H. [3 ]
de Boer, Onno J. [3 ]
den Haan, Joke M. M. [4 ]
Hendriks, Rudi W. [5 ]
van 't Veer, Cornelis [1 ,2 ]
van der Poll, Tom [1 ,2 ,6 ]
de Vos, Alex F. [1 ,2 ]
机构
[1] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Acad Med Ctr, Ctr Expt & Mol Med CEMM, Amsterdam, Netherlands
[2] Amsterdam Univ Med Ctr UMC, Amsterdam Infect & Immun Inst AI&II, Amsterdam, Netherlands
[3] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands
[4] Vrile Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands
[5] Univ Med Ctr, Erasmus Med Ctr Rotterdam, Dept Pulm Med, Rotterdam, Netherlands
[6] Univ Amsterdam, Amsterdam Univ Med Ctr UMC, Acad Med Ctr, Div Infect Dis, Amsterdam, Netherlands
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
关键词
BTK; Bruton's tyrosine kinase; X-linked immunodeficiency; natural antibodies; Streptococcus pneumoniae; pneumonia; sepsis; myeloid cells; mice; X-LINKED AGAMMAGLOBULINEMIA; HOST-DEFENSE; STREPTOCOCCUS-PNEUMONIAE; NEUTROPHIL RECRUITMENT; ALVEOLAR MACROPHAGES; INTEGRIN ACTIVATION; TRANSGENIC MICE; BTK; EXPRESSION; DEFICIENCY;
D O I
10.3389/fimmu.2021.723967
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bruton's tyrosine kinase (Btk) is a cytoplasmic kinase expressed in B cells and myeloid cells. It is essential for B cell development and natural antibody-mediated host defense against bacteria in humans and mice, but little is known about the role of Btk in innate host defense in vivo. Previous studies have indicated that lack of (natural) antibodies is paramount for impaired host defense against Streptococcus (S.) pneumoniae in patients and mice with a deficiency in functional Btk. In the present study, we re-examined the role of Btk in B cells and myeloid cells during pneumococcal pneumonia and sepsis in mice. The antibacterial defense of Btk(-/-) mice was severely impaired during pneumococcal pneumosepsis and restoration of natural antibody production in Btk(-/-) mice by transgenic expression of Btk specifically in B cells did not suffice to protect against infection. Btk(-/-) mice with reinforced Btk expression in MhcII(+) cells, including B cells, dendritic cells and macrophages, showed improved antibacterial defense as compared to Btk(-/-) mice. Bacterial outgrowth in Lysmcre-Btk(fl)/Y mice was unaltered despite a reduced capacity of Btk-deficient alveolar macrophages to respond to pneumococci. Mrp8cre-Btk(fl)/Y mice with a neutrophil specific paucity in Btk expression, however, demonstrated impaired antibacterial defense. Neutrophils of Mrp8cre-Btk(fl)/Y mice displayed reduced release of granule content after pulmonary installation of lipoteichoic acid, a gram-positive bacterial cell wall component relevant for pneumococci. Moreover, Btk deficient neutrophils showed impaired degranulation and phagocytosis upon incubation with pneumococci ex vivo. Taken together, the results of our study indicate that besides regulating B cell-mediated immunity, Btk is critical for regulation of myeloid cell-mediated, and particularly neutrophil-mediated, innate host defense against S. pneumoniae in vivo.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Targeting Bruton's tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments
    Tavakoli, Gita Manzari
    Yazdanpanah, Niloufar
    Rezaei, Nima
    ADVANCES IN RHEUMATOLOGY, 2024, 64 (01):
  • [32] THE NOVEL BRUTON'S TYROSINE KINASE INHIBITOR ARQ531, DISRUPTS SURVIVAL SIGNALING AND TRIGGERS APOPTOSIS IN AML CELLS
    Soncini, D.
    Minetto, P.
    Ruberti, S.
    Retali, V.
    Orecchioni, S.
    Contini, P.
    Cagnetta, A.
    Eathiraj, S.
    Abbadessa, G.
    Schwartz, B.
    Nencioni, A.
    Todoerti, K.
    Agnelli, L.
    Bertolini, F.
    Neri, A.
    Gobbi, M.
    Lemoli, R. M.
    Cea, M.
    HAEMATOLOGICA, 2018, 103 : S71 - S71
  • [33] Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells
    Wang, Jingming
    Lau, Kai-Yeung
    Jung, Jimmy
    Ravindran, Palanikumar
    Barrat, Franck J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (04) : 1130 - 1136
  • [34] The novel Bruton's tyrosine kinase inhibitor ARQ531 disrupts survival signaling and triggers apoptosis in AML cells
    Debora, Soncini
    Orecchioni, Stefania
    Cagnetta, Antonia
    Retali, Veronica
    Ruberti, Samantha
    Minetto, Paola
    Contini, Paola
    Nencioni, Alessio
    Monacelli, Fiammetta
    Hall, Terence
    Gobbi, Marco
    Eathiraj, Sudharshan
    Schwartz, Briam
    Bertolini, Francesco
    Lemoli, Roberto
    Cea, Michele
    CANCER RESEARCH, 2018, 78 (13)
  • [35] Antihistamines are synergistic with Bruton's tyrosine kinase inhibiter ibrutinib mediated by lysosome disruption in chronic lymphocytic leukemia (CLL) cells
    Chanas-Larue, Aaron
    Villalpando-Rodriguez, Gloria E.
    Henson, Elizabeth S.
    Johnston, James B.
    Gibson, Spencer B.
    LEUKEMIA RESEARCH, 2020, 96
  • [36] Cytokine-Mediated Signaling Is Suppressed in Myeloid Cells and Enhanced in Lymphatic Cells in Patients with Chronic Myeloid Leukemia (CML) - Partial Normalization with Tyrosine Kinase Inhibitors
    Jalkanen, Sari
    Mustjoki, Satu
    Porkka, Kimmo
    Vakkila, Jukka
    BLOOD, 2009, 114 (22) : 858 - 858
  • [37] Ca2+-independent activation of Bruton's tyrosine kinase is required for store-mediated Ca2+ entry in human platelets
    Redondo, PC
    Ben-Amor, N
    Salido, GM
    Bartegi, A
    Pariente, JA
    Rosado, JA
    CELLULAR SIGNALLING, 2005, 17 (08) : 1011 - 1021
  • [38] Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells
    Bame, Eris
    Tang, Hao
    Burns, Jeremy C.
    Arefayene, Million
    Michelsen, Klaus
    Ma, Bin
    Marx, Isaac
    Prince, Robin
    Roach, Allie M.
    Poreci, Urjana
    Donaldson, Douglas
    Cullen, Patrick
    Casey, Fergal
    Zhu, Jing
    Carlile, Thomas M.
    Sangurdekar, Dipen
    Zhang, Baohong
    Trapa, Patrick
    Santoro, Joseph
    Muragan, Param
    Pellerin, Alex
    Rubino, Stephen
    Gianni, Davide
    Bajrami, Bekim
    Peng, Xiaomei
    Coppell, Alex
    Riester, Katherine
    Belachew, Shibeshih
    Mehta, Devangi
    Palte, Mike
    Hopkins, Brian T.
    Scaramozza, Matthew
    Franchimont, Nathalie
    Mingueneau, Michael
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (06)
  • [39] Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
    Stiff, Andrew
    Trikha, Prashant
    Wesolowski, Robert
    Kendra, Kari
    Hsu, Vincent
    Uppati, Sarvani
    McMichael, Elizabeth
    Duggan, Megan
    Campbell, Amanda
    Keller, Karen
    Landi, Ian
    Zhong, Yiming
    Dubovsky, Jason
    Howard, John Harrison
    Yu, Lianbo
    Harrington, Bonnie
    Old, Matthew
    Reiff, Sean
    Mace, Thomas
    Tridandapani, Susheela
    Muthusamy, Natarajan
    Caligiuri, Michael A.
    Byrd, John C.
    Carson, William E., III
    CANCER RESEARCH, 2016, 76 (08) : 2125 - 2136
  • [40] Mavorixafor enhances efficacy of Bruton tyrosine kinase inhibitors by overcoming the protective effect of bone marrow stroma on tumor cells in Waldenstrom's macroglobulinemia
    Nguyen, Chi
    Monticelli, Halenya
    Kruitwagen, Tom
    Tardelli, Matteo
    Maierhofer, Barbara
    Rebelo, Thalia Martins
    Maier-Munsa, Sabine
    Zmajkovicova, Katarina
    Dillinger, Lukas
    Badarau, Adriana
    Taveras, Arthur G.
    CANCER RESEARCH, 2022, 82 (12)